Daehwa Warfarin Sodium Tablet 2 mg

Adult dose

There are individual differences according to PT/INR and specific genotypes of the CYP2C9 and VKORC1 genes (see 4. General Precautions under Precautions for Use), but the usual initial dose is 2～5 mg of warfarin sodium once daily, and the maintenance dose is 2～10 mg once daily. A lower dose is recommended for elderly or debilitated patients.

This medication is a blood thinner used to prevent thrombus formation. However, individuals who are allergic to this drug, have bleeding disorders, or conditions that predispose them to bleeding should not take it. Patients with very poor liver or kidney function, severe hypertension, those who have recently undergone major surgery, people with vitamin K deficiency, and pregnant women should also avoid this medication. Furthermore, patients with alcohol addiction or mental disorders, and those who have undergone a spinal tap or anesthesia should avoid this drug. When taking this medication, patients with high bleeding risks, elderly individuals, frail persons, and those with a history of gastrointestinal ulcers should exercise special caution. Frequent blood tests to monitor coagulation status are necessary, and medication dosage should be adjusted according to individual age, gender, and genetic characteristics. This drug is potent and has a long duration of action, which may pose a bleeding risk; if bleeding symptoms appear, you should immediately discontinue the medication and consult your doctor. Be cautious of foods high in vitamin K, alcohol consumption, and concomitant use of certain medications, as they can alter the effects of the drug. It is advisable to avoid activities that may result in injury during exercise or other physical activities. This medication may have rare side effects, such as skin necrosis; any abnormalities on the skin should be reported immediately. Women who are pregnant or may become pregnant should not take this medication, and breastfeeding women should also be cautious as it may affect the baby. The safety and efficacy of this medication have not been sufficiently established in children; therefore, its use is not recommended.

• Hemorrhage
• gastrointestinal bleeding
• urethral bleeding
• submucosal bleeding
• wall bleeding
• paralytic ileus
• visceral disorder
• excessive uterine bleeding
• hemorrhagic necrosis
• adrenal hemorrhage

This medication may be sensitive to light, so it should be stored in a closed container that blocks light. Additionally, it is best to store it at room temperature between 1 and 30 degrees Celsius. This storage method will help maintain the drug's efficacy and safety.

Appearance

White round tablets

Package unit

For domestic use - 30 tablets/bottle, For domestic use - 300 tablets/bottle, For export - 100 tablets/box [(10 tablets/blister x 10)]